Search for other papers by Isabelle Clinckspoor in
Google Scholar
PubMed
Search for other papers by Anne-Catherine Gérard in
Google Scholar
PubMed
Search for other papers by Jacqueline Van Sande in
Google Scholar
PubMed
Search for other papers by Marie-Christine Many in
Google Scholar
PubMed
Search for other papers by Lieve Verlinden in
Google Scholar
PubMed
Search for other papers by Roger Bouillon in
Google Scholar
PubMed
Search for other papers by Geert Carmeliet in
Google Scholar
PubMed
Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium
Search for other papers by Chantal Mathieu in
Google Scholar
PubMed
Search for other papers by Annemieke Verstuyf in
Google Scholar
PubMed
Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Introduction 1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ], the active form of vitamin D, is mainly known for its effects on calcium and phosphate homeostasis with bone, intestine and kidney as principal target tissues. However, 1,25(OH) 2 D 3
Department of Endocrinology, Skåne University Hospital, Malmö, Sweden
Search for other papers by Tereza Planck in
Google Scholar
PubMed
Search for other papers by Bushra Shahida in
Google Scholar
PubMed
Search for other papers by Johan Malm in
Google Scholar
PubMed
Department of Surgery, Skåne University Hospital, Malmö, Sweden
Search for other papers by Jonas Manjer in
Google Scholar
PubMed
Introduction In recent years, the extraskeletal effects of vitamin D have been extensively studied. Vitamin D deficiency is linked to a variety of autoimmune disorders, including autoimmune thyroid disease [ 1 ]. Genetic variation in genes
University of Sheffield, Sheffield, UK
Search for other papers by Muhammad Fahad Arshad in
Google Scholar
PubMed
Search for other papers by Amardass Dhami in
Google Scholar
PubMed
Search for other papers by Gillian Quarrell in
Google Scholar
PubMed
University of Sheffield, Sheffield, UK
Search for other papers by Saba Prakash Balasubramanian in
Google Scholar
PubMed
Introduction Hypoparathyroidism is defined as low calcium levels in presence of inappropriately normal or low parathyroid hormone (PTH) levels ( 1 ). It is commonly treated with calcium and activated vitamin D supplements, which makes it the
Search for other papers by N. Papanikolaou in
Google Scholar
PubMed
Search for other papers by P. Perros in
Google Scholar
PubMed
[ 14 ]. The coexistence of Graves’ disease and myasthenia gravis is rare but well recognized [ 9 , 15 ]. Polymyositis has also been associated with Graves’ disease [ 8 , 16 ]. On the other hand, increasing evidence indicates that vitamin D plays an
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Marenza Leo in
Google Scholar
PubMed
Search for other papers by Maria Antonietta Altea in
Google Scholar
PubMed
(GSH) and vitamins (ascorbic acid and tocopherol). Any increase in the rate of ROS production or decrease in their scavenging ability will disrupt the oxidative stability of the cell, resulting in oxidative stress (fig. 1 ) [ 4 ]. Fig. 1
Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
Search for other papers by Caroline M J van Kinschot in
Google Scholar
PubMed
Search for other papers by Ivona Lončar in
Google Scholar
PubMed
Search for other papers by Tessa M van Ginhoven in
Google Scholar
PubMed
Search for other papers by W Edward Visser in
Google Scholar
PubMed
Search for other papers by Robin P Peeters in
Google Scholar
PubMed
Search for other papers by Charlotte van Noord in
Google Scholar
PubMed
Search for other papers by the Thyroid Network Study Group † in
Google Scholar
PubMed
management are absent. The optimal treatment strategy is much debated in literature ranging from prophylactic calcium with or without active vitamin D supplementation in all thyroidectomy patients to selective supplementation based on biochemical parameters
Search for other papers by Sylvie Hiéronimus in
Google Scholar
PubMed
Search for other papers by Patricia Ferrari in
Google Scholar
PubMed
Search for other papers by Jocelyn Gal in
Google Scholar
PubMed
Search for other papers by Frédéric Berthier in
Google Scholar
PubMed
Search for other papers by Stéphane Azoulay in
Google Scholar
PubMed
Search for other papers by André Bongain in
Google Scholar
PubMed
Institut National de la Recherche Médicale, UMR U895, University Nice-Sophia-Antipolis, Nice, France
Search for other papers by Patrick Fénichel in
Google Scholar
PubMed
Institut National de la Recherche Médicale, UMR U895, University Nice-Sophia-Antipolis, Nice, France
Search for other papers by Françoise Brucker-Davis in
Google Scholar
PubMed
into two groups, one group receiving iodine-enriched pregnancy vitamins (150 µg/day, Oligobs Maxiode, Laboratoire C.C.D., Paris, France) and the other group receiving the same vitamin mix but without iodine (Oligobs grossesse, Laboratoire C.C.D.). The
Search for other papers by Camille Galy-Bernadoy in
Google Scholar
PubMed
Search for other papers by Benjamin Lallemant in
Google Scholar
PubMed
Search for other papers by Guillaume Chambon in
Google Scholar
PubMed
Search for other papers by Huy Trang Pham in
Google Scholar
PubMed
Search for other papers by Christophe Reynaud in
Google Scholar
PubMed
Search for other papers by Caroline Alovisetti in
Google Scholar
PubMed
Search for other papers by Quentin Bonduelle in
Google Scholar
PubMed
Search for other papers by Anne Marie Guedj in
Google Scholar
PubMed
Search for other papers by Serge Lumbroso in
Google Scholar
PubMed
Search for other papers by David-Paul De Brauwere in
Google Scholar
PubMed
65% for the PTH Roche group and 81% of patients for the Beckman-Coulter group. For all these patients, a PTH SC value above this threshold value allowed a prompt discharge at days 0 and 1 postoperatively, and avoidance of a unnecessary vitamin D and
Search for other papers by Jan Debeij in
Google Scholar
PubMed
Departments of Thrombosis and Haemostasis, Leiden University Medical Centre, Leiden
Search for other papers by Suzanne C. Cannegieter in
Google Scholar
PubMed
Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands
Search for other papers by Bregje van Zaane in
Google Scholar
PubMed
Search for other papers by Anton P. van Zanten in
Google Scholar
PubMed
Departments of Thrombosis and Haemostasis, Leiden University Medical Centre, Leiden
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Centre, Leiden
Search for other papers by Frits R. Rosendaal in
Google Scholar
PubMed
Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands
Search for other papers by Victor E.A. Gerdes in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Centre, Leiden
Search for other papers by Pieter H. Reitsma in
Google Scholar
PubMed
Departments of Endocrinology and Metabolism, Leiden University Medical Centre, Leiden
Search for other papers by Olaf M. Dekkers in
Google Scholar
PubMed
Introduction Vitamin K antagonist (VKA) treatment is used for several indications where anticoagulation is needed, such as the treatment and prevention of venous thrombosis or the prevention of cerebrovascular accidents in patients with atrial
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Laura P.B. Elbers in
Google Scholar
PubMed
Search for other papers by Hjalmar A. Boon in
Google Scholar
PubMed
Search for other papers by Maaike I. Moes in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Bregje van Zaane in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Dees P.M. Brandjes in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Harry R. Büller in
Google Scholar
PubMed
Einthoven Laboratory for Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Suzanne Cannegieter in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Victor E.A. Gerdes in
Google Scholar
PubMed
, Stuijver DJ, Dentali F, Ageno W, Gerdes VE: The effect of subclinical hypothyroidism on vitamin k antagonist treatment. Thromb Res 2012;129:520-522. 10.1016/j.thromres.2011.11.009 22127212 11 Kurnik D, Loebstein R, Farfel Z, Ezra D, Halkin H